Republican lawmakers released a draft of a new bill that aims to stem drug shortages after Republicans in the House Energy and Commerce Committee blocked efforts by their Democratic colleagues to tackle drug shortages in the reauthorization of a key pandemic preparedness bill.
The draft bill, called the Stop Drug Shortages Act, would attempt to correct some of the mismatched financial incentives that contribute to drug shortages. It would also increase disclosure requirements for generic drug sponsors, give more authority to the FDA and offer an additional exclusivity incentive for companies that carry out shelf-life extension studies.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters